Sun Ups Stake In Taro

February 2008 | M&A Analysis

It seems that India's Sun Pharmaceutical Industries is growing impatient with opposition to its proposed acquisition of Israel's Taro Pharmaceutical Industries from some of Taro's major stakeholders, Sun has purchased the shares of a key opponent to the deal. The purchase of 3,712,557 Taro shares from Brandes Investment Partners will raise Sun's stake in Taro to 34.4%.

If you would like to subscribe to Corporate Financing Week and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Corporate Financing Week please click on the trial link below.